Elly

Neutral
BETA

The empathetic audio companion for people impacted by cancer.

Analytics

Raised to Date: $0

Aggregate Commitments $
Platform

SeedInvest

Start Date

10/06/2020

Close Date

11/20/2020

Min. Goal

$25,000

Max. Goal

$1,000,000

Min. Investment

$1,000

Security Type

Convertible Note

Funding Type

RegCF

Series

Pre-Seed

Valuation Cap

$5,000,000

Discount Rate

20%

Weekly Commitments $
Status
Not Funded
Reporting Date

11/22/2020

Days Remaining
Not Funded
% of Min. Goal

0%

% of Max. Goal

0%

Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Location

Los Angeles, CA

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

High

Capital Intensity

Low

Business Type

Growth

Elly, with a valuation cap of $5 million, is raising funds on SeedInvest. It is an empathetic audio companion for patients who have cancer. The friendly voice and companionship of Elly help improve the emotional wellbeing and quality of life of patients. Every day, Elly talks about an oncology topic, references a motivational story, and leaves an inspirational message for the patients. Simon Holland and Nikhil Pooviah founded Elly in 2019 and raised over $550,000 in previous rounds of funding. The current crowdfunding round has a minimum raise of $25,000 and a maximum raise of $1,000,000, and the proceeds will be used for content, research, marketing, product, and growth. The users of Elly reported a 10% improvement in their quality of life scores in a clinical study of 100 patients.

Summary Profit and Loss Statement
Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-50,645

$0

Summary Balance Sheet
Most Recent Year Prior Year

Cash

$57,900

$0

Accounts Receivable

$0

$0

Total Assets

$57,900

$0

Short-Term Debt

$8,455

$75,000

Long-Term Debt

$75,000

$0

Total Liabilities

$83,455

$75,000

Ratings

last updated 11/19/2020

Ratings Platform - Beta Trial

Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.

For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.

Analyst Report

Neutral
Ratings Platform - Beta Trial

Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.

For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.
Other Deals

UpLyft on Wefunder

UpLyft has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
HealtheMed on Wefunder

HealtheMed has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Biopact on Equifund CFP

Biopact has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Elly on SeedInvest
Follow company
Follow Elly on SeedInvest